{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"columns":[{"gene":"","key":"MONDO:0007327/OMIM:118830","label":"Chylomicronemia, familial, due to circulating inhibitor of lipoproteinlipase","mondoId":"MONDO:0007327","onsetQualifier":null,"recordKeys":["4681162a9ad4e8b1983103f14aa4300fd76fd4f6d68e6c58911e40d046cb324a","5e5ea786f49c36d107744728676d53fc29d67e48a170912552320860ca06e9d7","71629d3cd02291700ad6e6dad9963adaee64cfb4188c16fa607585837721e630","cca9d4c37d275070c80e9cdd69dd44e2788529563df413523e4c935232af0d92"],"recordQualifiers":{},"scopeLabel":"OMIM:118830","sourceIds":["OMIM:118830"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show initial comparisons","defaultColumnKeys":["MONDO:0007327/OMIM:118830"],"expandColumnsLabel":"Compare all source entries","intro":"Compare the original source entries. Different entries may describe different patient groups.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column keeps its native condition scope. Initial features are displayed alphabetically, not ranked by clinical importance. Counts remain separate, and an empty cell does not mean a feature cannot occur.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":4,"sourceGroups":{"omim":4,"orphanet":0,"published":0}},"features":[{"hpoId":"HP:0002027","label":"Abdominal pain","primary":false},{"hpoId":"HP:0010980","label":"Hyperlipoproteinemia","primary":false},{"hpoId":"HP:0100027","label":"Recurrent pancreatitis","primary":false},{"hpoId":"HP:0001744","label":"Splenomegaly","primary":false}],"ledeHtml":"A patient-friendly description is not yet available in the ingested narrative sources for this condition.","mondoId":"MONDO:0007327","records":[{"frequencyKind":"reported","key":"4681162a9ad4e8b1983103f14aa4300fd76fd4f6d68e6c58911e40d046cb324a","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:118830","disease_name":"Chylomicronemia, familial, due to circulating inhibitor of lipoproteinlipase","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0010980","is_excluded":false,"label":"Hyperlipoproteinemia","onset_id":null,"reference":"OMIM:118830","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"5e5ea786f49c36d107744728676d53fc29d67e48a170912552320860ca06e9d7","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:118830","disease_name":"Chylomicronemia, familial, due to circulating inhibitor of lipoproteinlipase","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0100027","is_excluded":false,"label":"Recurrent pancreatitis","onset_id":null,"reference":"OMIM:118830","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"71629d3cd02291700ad6e6dad9963adaee64cfb4188c16fa607585837721e630","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:118830","disease_name":"Chylomicronemia, familial, due to circulating inhibitor of lipoproteinlipase","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001744","is_excluded":false,"label":"Splenomegaly","onset_id":null,"reference":"OMIM:118830","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"cca9d4c37d275070c80e9cdd69dd44e2788529563df413523e4c935232af0d92","raw":{"aspect":"P","body_system":"other","disease_id":"OMIM:118830","disease_name":"Chylomicronemia, familial, due to circulating inhibitor of lipoproteinlipase","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002027","is_excluded":false,"label":"Abdominal pain","onset_id":null,"reference":"OMIM:118830","source_release":"2026-06-23"},"sourceGroups":["omim"]}],"referenceLabels":{},"references":{"causeHtml":"<p>No mapped MedlinePlus condition document in this snapshot.</p>","identityNote":"MONDO defines condition identity and route membership. Native evidence populations and narrative coverage retain their separate scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>No MedlinePlus narrative has been mapped to this MONDO condition. Feature annotations, when available, are retained below.</p>","key":"overview","title":"Condition overview"}],"sharedSources":[],"slug":"chylomicronemia-familial-due-to-circulating-inhibitor-of-lipoprotein-lipase","sourceDocuments":[],"sourceNote":"MONDO condition identity; scoped MedlinePlus enrichment where available; original HPO annotations.","takeawayHtml":"Cause information is not available in the mapped narrative sources for this condition.","title":"chylomicronemia, familial, due to circulating inhibitor of lipoprotein lipase"},"schemaVersion":1}